SCHEMBL28419775

SCHEMBL28419775

COc1ccn2cc(C(C)=O)c(C(=O)Nc3cccc(-c4cnn(Cc5ccccc5)c4)c3F)c2c1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CREBBP Q92793 7/20 0.46
▸ KDM4E B2RXH2 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ HPGD P15428 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ POLQ O75417 1/20 0.42
▸ EP300 Q09472 1/20 0.40
▸ BRD2 P25440 1/20 0.40
▸ BRD3 Q15059 1/20 0.40
▸ EPHB3 P54753 1/20 0.40
▸ SCD5 Q86SK9 3/20 0.40
▸ SCD O00767 3/20 0.39
▸ BCL2L1 Q07817 1/20 0.39
▸ DGAT2 Q96PD7 1/20 0.39
▸ KLKB1 P03952 1/20 0.38
▸ RIPK1 Q13546 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28415697 0.87 CREBBP (0.58) CREBBPEP300BRD2BRD3EPHB3
SCHEMBL28411099 0.86 KDM4E (0.44) CREBBPKDM4EALDH1A1EP300BRD2
SCHEMBL28410723 0.86 CREBBP (0.45) CREBBPKDM4EEP300BRD2BRD3
SCHEMBL28881183 0.85 CREBBP (0.64) CREBBPPOLQEP300BRD2BRD3
SCHEMBL28415713 0.85 CREBBP (0.46) CREBBPEP300BRD2BRD3EPHB3
SCHEMBL28417785 0.83 CREBBP (0.44) CREBBPEP300BRD2BRD3EPHB3
SCHEMBL28413189 0.83 CREBBP (0.58) CREBBPEP300BRD2BRD3EPHB3
SCHEMBL28416810 0.83 ABCB1 (0.45) CREBBPKDM4EALDH1A1BRD2BRD3
SCHEMBL28891091 0.80 CREBBP (0.41) CREBBPKDM4EEP300BRD2BRD3
SCHEMBL28418305 0.79 CREBBP (0.43) CREBBPEP300BRD2BRD3EPHB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111320621-A Indolizine compound and preparation method and application thereof 中国科学院广州生物医药与健康研究院 2020-06-23 — — CN disclosed
Send feedback